Chemotherapy Doctors Abroad — Page 2

Professor of Medical Oncology specializing in gastrointestinal cancers – Prof. Sağlam works at Gayrettepe Florence Nightingale Hospital.

• Medical oncology fellowship at Istanbul University
• Special focus on gastrointestinal oncology cases
• Member of ESMO, ASCO, and European Neuroendocrine Tumor Society
• Over 27 years experience in medical oncology

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Dr. Onder Surgit is a professor of general surgery at Optimed International Hospital. He is a surgical instructor at the Advanced Medical Technologies Training Center (ITEM). Dr. Surgit treats cancer, obesity, and complex gastrointestinal conditions. He applies laparoscopic techniques for weight loss and tumor removal.

• Specializes in bariatric surgery including gastric sleeve, bypass, and balloon procedures.
• Performs oncological surgeries for breast, lung, stomach, and colon cancer.
• Served as a faculty member at Turgut Ozal and Atilim Universities.
• Works at AACI-accredited Optimed International Hospital in Tekirdag, Turkey.

Specializes in integrative cancer treatments – Rana Niftaliyeva combines chemotherapy with mistletoe therapy and high-dose vitamin C to reduce side effects.

• Handles hormonal treatment for breast cancer
• Expert in managing complications from chemotherapy
• Treats precancerous conditions and symptomatic care
• Participated in international conferences with German specialists

Dr. Hana Golan heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation Division at Sheba Medical Center. She specializes in high-risk pediatric tumors and complex childhood cancers. Dr. Golan serves as the principal investigator for the High-Risk Neuroblastoma ESIOP protocol. She practices at a hospital ranked among the global top 10 by Newsweek.

• National coordinator of multicenter oncology protocols and international Phase I/II clinical trials.
• Performs bone marrow transplants and CAR T-cell therapy for pediatric patients.
• Expert in neuroblastoma, leukemia, and treatment-resistant malignancies.
• Senior Lecturer at the Sackler Faculty of Medicine at Tel Aviv University.

Prof. Bozkurt specializes in pediatric oncology with advanced training at Harvard's Dana-Farber Cancer Institute and Cincinnati Children's Hospital.

• Over 36 years of experience in pediatric hematology-oncology
• Vice Director of the Stem Cell Transplant Unit at Medical Park
• Published 40+ peer-reviewed articles on childhood cancers

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Prof. Amit Tirosh heads Sheba Medical Center's Neuroendocrine Tumors Service and leads research in endocrine oncology with international collaborations.

• Specializes in hereditary NET syndromes like MEN1 and VHL
• Trained at National Institutes of Health in endocrine tumor genetics
• 40+ publications on NET treatments in top medical journals
• Provides advanced therapies including peptide NPVfgsnerceptor radionuclide therapy
• Member of European Neuroendocrine Tumors Society

Dr. Osama Abdel Mohimen Mohamed leads the Hematology Unit at Shefaa Al Orman Oncology Hospital. He treats complex blood cancers, including leukemia, lymphoma, and myeloma. Dr. Mohamed is a member of the European Society for Medical Oncology. He also holds memberships in the American Society of Hematology and ASBMT.

• Specializes in chemotherapy, immunotherapy, and bone marrow transplantation.
• Manages aggressive acute leukemia and chronic blood disorders.
• Treats complications arising from various solid tumors.
• Works at an ESMO-accredited center that handles 6,000 patients annually.

Dr. Altay Aliyev specializes in advanced chemotherapy techniques, including targeted treatments and immunotherapy, at Liv Bona Dea Hospital Baku.

• Trained at Istanbul University and Cleveland Clinic
• Published multiple research papers on cancer treatments
• Expert in cytotoxic chemotherapy and hormone therapy
• Focused on early diagnosis and palliative care

Dr. Mehmet Salih Iyikesici is a medical oncologist. His work focuses on metabolically supported chemotherapy (MSCT), ketogenic diet–supported cancer care, hyperthermia, hyperbaric oxygen therapy, and insulin potentiation therapy. He emphasizes care for breast, pancreatic, and gastric cancers.

He is a Medical Oncology Specialist at Neolife Medical Center (2026–present). He previously served at Private Bahçelievler Medical Park (2013–2026), Medicana Beylikdüzü (2010–2013), Silivri Anadolu (2009–2010), Diyarbakır Training and Research (2008–2009), and Bursa Çekirge State (2006–2008). Earlier, he worked as an Internal Medicine Specialist (1997–2003). He was an Assistant Professor at Altınbaş University (2014–2026).

Training: Medical Oncology subspecialty, Marmara University (2003–2006). Internal Medicine, Istanbul Haydarpaşa Numune (1992–1996). Medicine, Uludağ University (1985–1990). Member, Medical Oncology Association (since 2004). His recent research (2019–2020) covers gastric, breast, pancreatic, and lung cancers. Topics include long‑term survival in metastatic pancreatic cancer and feasibility in metastatic non‑small cell lung cancer (NSCLC).

Dr. Graupera heads the Hematology Oncology Department at Sant Joan De Déu – one of Europe's top children's hospitals. He specializes in pediatric sarcomas and neuroblastomas.

• Trained at Memorial Sloan Kettering Cancer Center in the USA
• Developed a radiation-free treatment for spinal cord gliomas
• Published 70+ papers on pediatric cancer treatments
• Recipient of multiple international oncology awards
• Scientific Director of pediatric cancer research programs

Specialist in bone marrow transplantation at SJD Barcelona Children's Hospital, focusing on pediatric hematology.

• Children's hematologist with expertise in chemotherapy
• Works at a leading children's hospital in Barcelona
• Specializes in treatments for young patients

Dr. Yuri Goldes is the Deputy Director of General Surgery at Sheba Medical Center. He pioneered some of Israel’s first robotic resections for stomach and pancreatic cancers. Forbes Israel named him among the nation’s best gastrointestinal surgeons. In 2019, he received the Best Doctor of the Year award from the Israeli Ministry of Health.

• Specializes in robotic and laparoscopic surgery for pancreatic, gastric, and esophageal cancers.
• Performs minimally invasive Whipple procedures, one of the most complex abdominal operations.
• Treats benign conditions including diaphragmatic hernia, achalasia, GERD, and gallbladder disease.
• Works at Sheba Medical Center, ranked among the Top 10 hospitals worldwide by Newsweek.

Dr. Ding Yi is the Associate Chief Physician in Hematology at Shanghai Tongji Hospital. She is also the acting deputy director of the Blood Transfusion Department. She holds a Master of Medicine from Tongji University. She serves on the Youth Committee of the Shanghai Society of Hematology.

She is skilled in diagnosing and treating leukemia, lymphoma, and myeloma. She offers hematopoietic and umbilical cord blood stem cell therapies. She specializes in acute leukemia. She developed sequential treatment protocols. She participated in research that won the Second Prize of the Shanghai Science and Technology Progress Award. She has published more than 10 papers.

Head of Breast Cancer Group at San Raffaele – Dr. Bianchini has co-investigated 100+ clinical trials and published 45+ papers on breast cancer.

• 21 years specializing in breast cancer oncology
• Leads clinical translational and immunotherapy research
• Co-inventor of a patent for personalized drug combinations
• Trained at MD Anderson Cancer Center in the US